Efficacy of weekly paclitaxel in patients with docetaxel-resistant metastatic breast cancer

By Yonemori Kan   Katsumata Noriyuki   Uno Hajime   Matsumoto Koji   Kouno Tsutomu   Tokunaga Shinya   Yamanaka Yasuhiro   Shimizu Chikako   Ando Masashi   Takeuchi Masahiro   Fujiwara Yasuhiro  

Breast Cancer Research and Treatment, Vol. 89, Iss. 3, 2005-02 ,pp. : 237-241

Springer Publishing Company

Access to resources Recommend Favorite

Weekly one-hour paclitaxel as first-line chemotherapy for metastatic breast cancer

By Wist Erik Andreas   Sommer Hilde Heen   Østenstad Bjørn   Risberg Terje   Fjæstad Knut  

Acta Oncologica, Vol. 43, Iss. 1, 2004-03 ,pp. : 11-14

Informa Healthcare

Access to resources Recommend Favorite

Combined endocrine treatment of elderly postmenopausal patients with metastatic breast cancer; A randomized trial of tamoxifen vs. tamoxifen + aminoglutethimide and hydrocortisone and tamoxifen + fluoxymesterone in women above 65 years of age

By Rose C.  

Breast Cancer Research and Treatment, Vol. 61, Iss. 2, 2000-05 ,pp. : 103-110

Springer Publishing Company

Access to resources Recommend Favorite

Safety and efficacy of neratinib in combination with weekly paclitaxel and trastuzumab in women with metastatic HER2-positive breast cancer: an NSABP Foundation Research Program phase I study

By Jankowitz Rachel   Abraham Jame   Tan Antoinette   Limentani Steven   Tierno Marni   Adamson Laura   Buyse Marc   Wolmark Norman   Jacobs Samuel  

Cancer Chemotherapy and Pharmacology, Vol. 72, Iss. 6, 2013-12 ,pp. : 1205-1212

Springer Publishing Company

Access to resources Recommend Favorite

Phase I Study with a Weekly 1 h Infusion of Paclitaxel in Heavily Pretreated Patients with Metastatic Breast and Ovarian Cancer

By Klaassen U.   Wilke H.   Strumberg D.   Eberhardt W.   Korn M.   Seeber S.  

European Journal of Cancer, Vol. 32, Iss. 3, 1996-03 ,pp. : 547-549

Elsevier

Access to resources Recommend Favorite